Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
Metrics: PDF 993 views | HTML 2125 views | ?
François Lallemand1,*, Ambre Petitalot1,2,*, Sophie Vacher1, Leanne de Koning3, Karim Taouis1, Bernard S. Lopez4, Sophie Zinn-Justin5, Nicole Dalla-Venezia6, Walid Chemlali1, Anne Schnitzler1, Rosette Lidereau1, Ivan Bieche1,7,* and Sandrine M. Caputo2,*
1Service de génétique, unité de pharmacogénomique, Institut Curie, Paris, France
2Service de génétique, unité de génétique constitutionnelle, Institut Curie, Paris, France
3Département de transfert, Institut Curie, Paris, France
4CNRS UMR 8200, Gustave Roussy Cancer Institute, Université Paris-Saclay, équipe labélisée par la Ligue contre le cancer, Villejuif, France
5Laboratoire de biologie structurale et radiobiologie, IBITEC-S (CEA) and I2BC (UMR 9198, CEA, CNRS, Univ. Paris South), Gif-sur-Yvette, France
6Centre de Recherche en Cancérologie de Lyon (CRCL)/INSERM U1052-CNRS UMR5286, Lyon, France
7EA7331, Université Paris Descartes, Paris, France
*These authors contributed equally to this work
Sandrine M. Caputo, email: email@example.com
Keywords: gynecological cancers; cervical squamous cell carcinoma; endometrial adenocarcinoma; uc.189; prognosis
Received: May 12, 2017 Accepted: December 22, 2017 Published: December 30, 2017
In mammals, FOXO transcriptional factors form a family of four members (FOXO1, 3, 4, and 6) involved in the modulation proliferation, apoptosis, and carcinogenesis. The role of the FOXO family in breast cancer remains poorly elucidated. According to the cellular context and the stage of the disease, FOXOs can have opposite effects on carcinogenesis. To study the role of FOXOs in breast carcinogenesis in more detail, we examined their expression in normal tissues, breast cell lines, and a large series of breast tumours of human origin. We found a very low physiological level of FOXO6 expression in normal adult tissues and high levels of expression in foetal brain. FOXO gene expressions fluctuate specifically in breast cancer cells compared to normal cells, suggesting that these genes may have different roles in breast carcinogenesis. For the first time, we have shown that, among the various FOXO genes, only FOXO6 was frequently highly overexpressed in breast cell lines and tumours. We also found that inhibition of the endogenous expression of FOXO6 by a specific siRNA inhibited the growth of the human breast cell lines MDA-MB-468 and HCC-38. FACS and Western blot analysis showed that inhibition of endogenous expression of FOXO6 induced accumulation of cells in G0/G1 phase of the cell cycle, but not apoptosis. These results tend to demonstrate that the overexpression of the human FOXO6 gene that we highlighted in the breast tumors stimulates breast carcinogenesis by activating breast cancer cell proliferation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.